Open Access
Subscription Access
Open Access
Subscription Access
Report of the Trial with 'Prolixan' as an Anti-Rheumatic Drug
Subscribe/Renew Journal
No Abstract
Keywords
No Keywords
Subscription
Login to verify subscription
User
Font Size
Information
Abstract Views: 259
PDF Views: 0